https://www.selleckchem.com/pr....oducts/gsk-j4-hcl.ht
Taken together, these data highlighted the potentials of lncRNA as targets for antiviral therapy and provided some novel knowledge of the mechanisms underlying the host interaction with PRV-II. To improve the innate and adaptive immune responses elicited by a killed/inactivated swine influenza virus antigen (KAg)-loaded chitosan nanoparticles (CS NPs-KAg), we used the adjuvant, poly(IC). The formulated CS NPs-KAg and CS NPs-poly(IC) had a net surface charge of +30.7 mV and +25.1 mV, respectively. The CS NPs-KAg was coadministered wit
Like
Comment
Share
